|
|||||
|
|
A vaccine to protect against peanut allergies, given as a nanoscale droplets suspended in a nasal spray, is shown to prevent allergic reactions in tests with lab mice sensitized to peanuts. . . . → Read More: Nasal Spray Vaccine Shown to Control Peanut Allergies A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal Early results from a clinical trial show implants of replacement retina cells grown from stem cells are safe for people with a form of age-related macular degeneration, and at least stop the loss of visual function. . . . → Read More: Stem Cell Eye Implants Safe, Stop Visual Function Loss Eli Lilly and Company is licensing a technology for implanting pancreatic beta cells in people with type 1 diabetes, from Sigilon Therapeutics Inc., an enterprise making implants of live cells to treat chronic diseases. . . . → Read More: Lilly, Cell Implants Start-Up Partner on Diabetes A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies  One comment - (Comments are closed)  Finance, Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, licensing, life sciences, patent, pharmaceuticals, venture capital A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells Comments are closed Intellectual property, New products biomedical, biotechnology, cancer, engineering, entrepreneurs, genomics, grant, licensing, life sciences, NIH, NSF, patent, pharmaceuticals, university A pharmaceutical researcher developed treatments for chronic pain, formulated as nanoscale droplets, that in tests with lab animals target the source of pain directly and use much smaller doses than current pain drugs. . . . → Read More: Nanotech Pain Drug Formulations Developed One comment - (Comments are closed) New products biomedical, life sciences, manufacturing, materials science, nanotechnology, pharmaceuticals, university MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets. . . . → Read More: Antibodies Licensed for Multi-Target Immunotherapies Comments are closed Intellectual property biomedical, biotechnology, cancer, genomics, Israel, licensing, life sciences, mathematics, pharmaceuticals, physical sciences A therapy for West Nile Virus made with interfering RNA molecules is shown in lab mice to reduce viral loads, including in the brain where the disease can do serious damage. . . . → Read More: RNA Treatment Tested for West Nile Virus Comments are closed New products biomedical, biotechnology, genomics, life sciences, pharmaceuticals, preclinical, university A clinical trial in Kenya shows blood from people who take a current anti-parasite drug can kill mosquitoes carrying malaria, offering a potential new strategy for controlling this disease. . . . → Read More: Drug Shown Able to Kill Malaria-Carrier Mosquitoes One comment - (Comments are closed) New products Africa, biomedical, clinical trials, Europe, health care, life sciences, pharmaceuticals, U.K., university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
